Essential tremor impacts 7 million Americans who navigate their condition without a targeted treatment. Finally, that’s about ...

New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly ...

A new research paper was published in Volume 17 of Oncotarget on April 28, 2026, titled "Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis ...

A phase 2b trial of Descartes-08, a BCMA-directed mRNA CAR T-cell therapy, in generalized myasthenia gravis demonstrated significant and lasting symptom improvement versus placebo, with one-third of ...

Deborah Stephens, DO, discusses long-term efficacy outcomes with targeted therapies in the treatment of patients with chronic ...

Targeted therapy is reaching more patients than ever, but access still depends on factors like cost, insurance coverage, geography, and cancer type. These treatments offer precision and strong ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

Long-term research indicates that starting rheumatoid arthritis patients on targeted biologic drugs like TNF inhibitors from diagnosis may reduce or delay progression to difficult-to-treat disease, ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Expert insights from Shagufta Shaheen, MD, on sequencing PRRT, everolimus, and cabozantinib after SSA progression in advanced ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. I am delighted to ...

Essential tremor impacts 7 million Americans who navigate their condition without a targeted treatment. Finally, that’s about ...